BACKGROUND: Most early-onset group B streptococcal (GBS) disease in recent years has occurred in newborns of prenatally GBS-negative mothers who missed intrapartum antibiotic prophylaxis (IAP). We aimed to assess the accuracy of prenatal culture in predicting GBS carriage during labor, the IAP use, and occurrence of early-onset GBS disease. METHODS: We obtained vaginal-rectal swabs at labor for GBS culture from 5497 women of ≥ 32 weeks' gestation and surface cultures at birth from newborns between February 5, 2008 and February 4, 2009 at 3 hospitals in Houston, TX and Oakland, CA. Prenatal cultures were performed by a healthcare provider during routine care, and culture results were obtained from medical records. The accuracy of prenatal culture in predicting intrapartum GBS carriage was assessed by positive and negative predictive values. Mother-to-newborn transmission of GBS was assessed. Newborns were monitored for early-onset GBS disease. RESULTS: GBS carriage was 24.5% by prenatal and 18.8% by labor cultures. Comparing prenatal with labor GBS cultures of 4696 women, the positive predictive value was 50.5% and negative predictive value was 91.7%. IAP, administered to 93.3% of prenatally GBS-positive women, was 83.7% effective in preventing newborn's GBS colonization. Mother-to-newborn transmission of GBS occurred in 2.6% of elective cesarean deliveries. Two newborns developed early-onset GBS disease (0.36/1000 births); the prenatal GBS culture of one was negative, the other's was unknown. CONCLUSIONS: IAP was effective in interrupting mother-to-newborn transmission of GBS. However, approximately 10% of prenatally GBS-negative women were positive during labor and missed IAP, whereas approximately 50% of prenatally GBS-positive women were negative during labor and received IAP. These findings emphasize the need for rapid diagnostics during labor.
BACKGROUND: Most early-onset group B streptococcal (GBS) disease in recent years has occurred in newborns of prenatally GBS-negative mothers who missed intrapartum antibiotic prophylaxis (IAP). We aimed to assess the accuracy of prenatal culture in predicting GBS carriage during labor, the IAP use, and occurrence of early-onset GBS disease. METHODS: We obtained vaginal-rectal swabs at labor for GBS culture from 5497 women of ≥ 32 weeks' gestation and surface cultures at birth from newborns between February 5, 2008 and February 4, 2009 at 3 hospitals in Houston, TX and Oakland, CA. Prenatal cultures were performed by a healthcare provider during routine care, and culture results were obtained from medical records. The accuracy of prenatal culture in predicting intrapartum GBS carriage was assessed by positive and negative predictive values. Mother-to-newborn transmission of GBS was assessed. Newborns were monitored for early-onset GBS disease. RESULTS:GBS carriage was 24.5% by prenatal and 18.8% by labor cultures. Comparing prenatal with labor GBS cultures of 4696 women, the positive predictive value was 50.5% and negative predictive value was 91.7%. IAP, administered to 93.3% of prenatally GBS-positive women, was 83.7% effective in preventing newborn's GBS colonization. Mother-to-newborn transmission of GBS occurred in 2.6% of elective cesarean deliveries. Two newborns developed early-onset GBS disease (0.36/1000 births); the prenatal GBS culture of one was negative, the other's was unknown. CONCLUSIONS: IAP was effective in interrupting mother-to-newborn transmission of GBS. However, approximately 10% of prenatally GBS-negative women were positive during labor and missed IAP, whereas approximately 50% of prenatally GBS-positive women were negative during labor and received IAP. These findings emphasize the need for rapid diagnostics during labor.
Authors: Arijaan W Valkenburg-van den Berg; Arwen J Sprij; Paul M Oostvogel; Johan A E M Mutsaers; Wouter B Renes; Frits R Rosendaal; P Joep Dörr Journal: Eur J Obstet Gynecol Reprod Biol Date: 2005-07-18 Impact factor: 2.435
Authors: L S Pulver; M M Hopfenbeck; P C Young; G J Stoddard; K Korgenski; J Daly; C L Byington Journal: J Perinatol Date: 2008-08-14 Impact factor: 2.521
Authors: Melissa K Van Dyke; Christina R Phares; Ruth Lynfield; Ann R Thomas; Kathryn E Arnold; Allen S Craig; Janet Mohle-Boetani; Ken Gershman; William Schaffner; Susan Petit; Shelley M Zansky; Craig A Morin; Nancy L Spina; Kathryn Wymore; Lee H Harrison; Kathleen A Shutt; Joseph Bareta; Sandra N Bulens; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag Journal: N Engl J Med Date: 2009-06-18 Impact factor: 91.245
Authors: J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile Journal: Eur J Clin Microbiol Infect Dis Date: 2012-09 Impact factor: 3.267
Authors: Isabella A Tickler; Fred C Tenover; Scott Dewell; Victoria M Le; Rachel N Blackman; Richard V Goering; Amy E Rogers; Heather Piwonka; Brittney D Jung-Hynes; Derrick J Chen; Michael J Loeffelholz; Devasena Gnanashanmugam; Ellen Jo Baron Journal: J Clin Microbiol Date: 2019-03-28 Impact factor: 5.948
Authors: Nai-Yu Wang; Kathryn A Patras; Ho Seong Seo; Courtney K Cavaco; Berenice Rösler; Melody N Neely; Paul M Sullam; Kelly S Doran Journal: J Infect Dis Date: 2014-03-11 Impact factor: 5.226
Authors: Ana Caroline N Botelho; Juliana G Oliveira; Andreia P Damasco; Késia T B Santos; Ana Flávia M Ferreira; Gabriel T Rocha; Penélope S Marinho; Rita B G Bornia; Tatiana C A Pinto; Marco A Américo; Sergio E L Fracalanzza; Lúcia M Teixeira Journal: PLoS One Date: 2018-05-11 Impact factor: 3.240
Authors: Daniel F Escobar; Diego A Diaz-Dinamarca; Carlos F Hernández; Daniel A Soto; Ricardo A Manzo; Pedro I Alarcón; Camila H Pinto; Diego N Bastias; Carolayn N Oberg-Bravo; Robert Rojas; Sebastián E Illanes; Alexis M Kalergis; Abel E Vasquez Journal: BMC Pregnancy Childbirth Date: 2020-06-09 Impact factor: 3.007